Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed News and Future Directions
New Mouse Model of Progressive MS Sheds Light on Aggressive Disease
New Math for MS Treatment
Biomarkers: Foretelling the Future
Oral Laquinimod May Reduce Destructive Pathology in RRMS
Cannabinoid Receptor Variant Linked to MS Neurodegeneration
CCSVI Not Linked to MS in Large Study
Study Reveals New Facets of NMO Pathophysiology
MS Research Roundup: April 4, 2014
Talking to Reporters: 13 Tips for Researchers
Switches to Fingolimod, Natalizumab Show Similar Efficacy
MS Research Roundup: August 13, 2014
Oral Cannabinoid Dronabinol Doesn’t Modify Disease in Progressive MS
MS Patient, Ph.D.: A Pregnant Pause
Meet the Microglia
Evidence Grows for Pathogenic Antibody
Anti-Inflammatory Apolipoprotein May Protect Against MS Symptoms
Sex Differences in MS Are Genetic, Not Just Hormonal
MS Research Roundup: February 26, 2014
Episode 79 with Dr. Nancy Monson on a diagnostic test to predict future risk for relapsing MS
Debate: Do Physicians Rate the Risk of Disabling MS Less Than the Risk of Effective Treatment?
MS Research Roundup: October 22, 2014
Novel Mouse Model of MS Allows Neuroprotective Drug Testing
PUMA Protein May Underlie Oligodendroglial Cell Death in MS
Episode 72 with Mr. Nathaniel Lizak on the MS disease course
A GWAS Gets Into Shape
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »